SCHEMBL4874249

SCHEMBL4874249

O=C(CN1CCN(C(=O)C(O)c2ccc(Cl)cc2)CC1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
SLC6A4 P31645 2/20 0.49
SLC6A3 Q01959 2/20 0.49
SLC6A9 P48067 1/20 0.47
KDR P35968 1/20 0.47
HTR1A P08908 1/20 0.46
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
ROCK2 O75116 1/20 0.45
CACNA2D1 P54289 4/20 0.45
CACNA1B Q00975 4/20 0.45
CACNB1 Q02641 4/20 0.45
CACNA1C Q13936 4/20 0.45
UTS2R Q9UKP6 2/20 0.44
CHRM3 P20309 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874296 0.82 ALDH1A1 (0.71) ALDH1A1SLC6A4SLC6A3KDRHTR1A
SCHEMBL22811884 0.79 ALDH1A1 (0.54) ALDH1A1SLC6A9CYP3A4MAPTROCK2
SCHEMBL14085833 0.77 ALDH1A1 (0.59) ALDH1A1SLC6A4SLC6A3KDRCYP3A4
SCHEMBL3840479 0.77 KDM4E (0.56) ALDH1A1SLC6A4SLC6A3KDRHTR1A
Hydrochloric Acid SCHEMBL4873626 0.76 KDM4E (0.55) ALDH1A1SLC6A4SLC6A3KDRHTR1A
SCHEMBL15340905 0.76 KMT2A (0.64) ALDH1A1KDRCYP3A4CYP2D6MAPT
SCHEMBL4875267 0.76 ALDH1A1 (0.79) ALDH1A1SLC6A4SLC6A3KDRCYP3A4
SCHEMBL21159094 0.74 POLB (0.57) ALDH1A1SLC6A4SLC6A3HTR1ACYP3A4
SCHEMBL20154465 0.74 ROCK2 (0.50) CYP3A4ROCK2CACNA2D1CACNA1BCACNB1
SCHEMBL4874422 0.73 KMT2A (0.66) ALDH1A1MAPK1MEN1KMT2AKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7326710-B2 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2008-02-05 US disclosed
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) 2005-07-14 US disclosed
EP-1553092-A1 ARALKYL FORMYL-ALKYL PIPERAZINE DERIVATIVES AND THEIR USES AS CEREBRAL NERVE PROTECTIVE AGENT Shanghai Institute of Pharmaceutical Industry (CN) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153981-A1 Aralkyl formly-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent GAP43, FABP7, AGK ALDH1A1 1828/4885SLC6A4 3781/4885SLC6A3 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.